THU0179 PATIENT AND THEIR ILLNESS – ATYPICAL SOURCES OF THERAPY RISKS. CHARACTERISTICS OF THE USE OF METHOTREXATE (MTX) AND FOLIC ACID (FA) SUPPLEMENTATION IN THERAPY LASTING MINIMUM 8 WEEKS IN ADULT PATIENTSWITH RHEUMATOID ARTHRITIS (RA)
Author:
Ligocki Piotr,Orlik Grzegorz,Vekariya Vishal
Publisher
BMJ Publishing Group Ltd and European League Against Rheumatism